Idenix Pharmaceuticals (IDIX) is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the U.S. and Europe. This stock is trading up 4% at $8.69 in recent trading.
Today's Range: $8.36-$8.7852-Week Range: $4.03-$15.25 Volume: 773,000 Three-Month Average Volume: 1.6 million >>5 Stocks That Could Crush the Bears From a technical perspective, IDIX is spiking notably higher here as the stock moves within range of a near-term breakout trade. That trade will hit once IDIX takes out some near-term overhead resistance at $9.25 to $9.30 with volume. Traders should look for long-biased trades if IDIX can sustain a move or close above those levels with volume that's near or above 1,609,720 shares. If we get that action soon, then IDIX can easily trend back towards its next significant overhead resistance levels at $10.42 to $11.92. Keep in mind that in order for IDIX to hit those targets, then this stock has to maintain a trend above its 50-day at $9.30 with strong upside volume flows.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV